Tyra Biosciences TYRA 深 滬
等待開盤 09-17 09:30:00 美东时间
24.35
-1.080
-4.25%
華盛通- 最 高26.15
- 今 開25.58
- 成交量 113.85万股
- 最 低 24.15
- 昨 收 25.43
- 總市值 16.74亿
- 52周最高 40.65
- 市盈率 靜 --
- 換手率 1.66%
- 52周最低 12.955
- 委 比 91.33%
- 總股本 6875.59万
- 歷史最高 40.65
- 量 比 0.43
- 振 幅 7.86%
- 歷史最低 4.93
- 每 手 1
- 風險率 7.61%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Tyra Bioscience announces $400M equity financing offering
Tyra Bioscience ( ($TYRA) ) just unveiled an update. On September 14, 2026, Tyr...
09-15 18:38
Tyra Biosciences Prices Underwritten Offering Of 9,079,000 Shares And Warrants At $22.03 Per Unit
Underwritten offering of 9,079,000 shares of its common stock at a price of $22.03 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase 9,078,529 shares of common stock at a purchase price of $22.029 per share, which equals the offering price per sha...
09-14 18:49
美股牛股 | Commerce劲升18%，宣布5000万美元股票回购计划；Wealthfront升逾15%，Clover Health升逾8%
Commerce劲升18%，宣布5000万美元股票回购计划；Wealthfront升逾15%，Q2营收超预期，平台资产突破千亿大关；Clover Health升逾8%，德银首予“买入”评级>>
09-11 19:01
美股大行评级 | 齐声看好医药股！礼来、强生、默沙东目标价均获上调；小摩大幅上调Meta目标价至820美元
今日重点评级关注：康托·菲茨杰拉德：维持SOL Strategies"超配"评级，目标价从2.8美元升至6.2美元；康托·菲茨杰拉德：维持Sui Group Holdings"超配"评级，目标价从1.7美元升至3.4美元
09-11 14:30
Why Is Tyra Biosciences Stock Sinking Wednesday?
Tyra Biosciences Inc. (NASDAQ:TYRA) stock is trading lower on Wednesday after the company shared initial results from its Phase 2 SURF302 trial evaluating oral dabogratinib, delivering clinical proof of concept and identifying a 60 mg once-daily dose to support planned registrational studies. The st...
09-10 00:39
美股牛股 | Belite Bio飙升13.2%，获大行看高至303美元，潜在升幅约77%；存储、光通信板块逆势狂涨！Aehr Test Systems劲升13%，闪迪升近12%
Belite Bio飙升13.2%，获大行看高至303美元，潜在升幅约77%；存储、光通信板块逆势狂涨！Aehr Test Systems劲升13%，闪迪升近12%>>
09-05 06:25
Tyra Biosciences To Discuss Initial Clinical Results From SURF302 Phase 2 Study Evaluating Oral Dabogratinib For IR NMIBC In Conference Call And Webcast On September 9
Tyra Biosciences, Inc. (NASDAQ:TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced that it will host a conference call and webcast on Wednesday, Se...
09-04 20:04
William Blair updates its stock Conviction List
William Blair added BJ’s Restaurants (BJRI), Aehr Test Systems (AEHR), MP Materials (MP), APi Group (APG), BrightSpring Health Services (BTSG), Curtiss-Wright (CW), James Hardie Industries (JHX) and U...
09-01 19:59
Tyra Biosciences shares are trading lower after the company reported worse-than-expected Q2 EPS results.
Tyra Biosciences shares are trading lower after the company reported worse-than-expected Q2 EPS results.
08-05 21:12
Tyra Biosciences Q2 EPS $(0.69) Misses $(0.65) Estimate
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.65) by 6.15 percent. This is a 46.81 percent decrease over losses of $(0.47) per share from the same period last year.
08-05 05:10
